1. Home
  2. STWD vs LQDA Comparison

STWD vs LQDA Comparison

Compare STWD & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

STWD

STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

N/A

Current Price

$16.38

Market Cap

6.2B

Sector

Real Estate

ML Signal

N/A

LQDA

Liquidia Corporation

N/A

Current Price

$68.62

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STWD
LQDA
Founded
2009
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.5B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
STWD
LQDA
Price
$16.38
$68.62
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$20.00
$41.00
AVG Volume (30 Days)
4.6M
1.6M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
10.64%
N/A
EPS Growth
4.55
51.81
EPS
0.15
1.26
Revenue
$1,844,289,000.00
$158,320,000.00
Revenue This Year
$283.44
$278.87
Revenue Next Year
$17.66
$57.13
P/E Ratio
$109.40
$56.39
Revenue Growth
N/A
1031.18
52 Week Low
$15.51
$21.15
52 Week High
$20.84
$93.61

Technical Indicators

Market Signals
Indicator
STWD
LQDA
Relative Strength Index (RSI) 48.98 35.96
Support Level $16.32 $31.99
Resistance Level $17.02 $92.35
Average True Range (ATR) 0.35 4.75
MACD 0.02 -2.21
Stochastic Oscillator 65.81 2.84

Price Performance

Historical Comparison
STWD
LQDA

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: